This R21 grant, offered by the funding department, is for the purpose of advancing pediatric drug development. It specifically encourages research applications that address diverse and complementary needs related to the creation and acceptability of drug formulations suitable for different pediatric age groups. A significant aspect of this initiative involves the development and thorough testing of novel drug delivery systems specifically designed for children. The overarching goal is to improve therapeutic outcomes by fostering innovative solutions for administering medications to younger populations. This funding opportunity aims to ensure children have access to safe, effective, and appropriately formulated medicines, bridging current gaps in pediatric pharmacotherapy research and application.
Opportunity ID: 241774
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PAR-13-326 |
| Funding Opportunity Title: | Development of Appropriate Pediatric Formulations and Pediatric Drug Delivery Systems (R21) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Health Income Security and Social Services |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.173 — Research Related to Deafness and Communication Disorders |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Sep 04, 2013 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | Sep 07, 2016 |
| Current Closing Date for Applications: | Sep 07, 2016 |
| Archive Date: | Oct 08, 2016 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | $200,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Public housing authorities/Indian housing authorities Independent school districts Special district governments Private institutions of higher education Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) For profit organizations other than small businesses Native American tribal governments (Federally recognized) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Public and State controlled institutions of higher education State governments City or township governments Others (see text field entitled “Additional Information on Eligibility” for clarification) County governments Small businesses |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | This Funding Opportunity Announcement (FOA) encourages grant applications to address different and complementary research needs for the development and acceptability of pediatric drug formulations in different age groups. Development and testing of novel pediatric drug delivery systems is also part of this initiative. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PAR-13-326.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-C | Forms-C | PKG00184691 | Sep 16, 2013 | May 07, 2016 | View | |
| FORMS-D | Use for due dates on or after May 25, 2016 | PKG00222401 | Apr 17, 2016 | Sep 07, 2016 | View |
Package 1
Mandatory forms
241774 RR_SF424_2_0-2.0.pdf
241774 PHS398_ResearchPlan_2_0-2.0.pdf
241774 PHS398_CoverPageSupplement_2_0-2.0.pdf
241774 RR_KeyPersonExpanded_2_0-2.0.pdf
241774 RR_OtherProjectInfo_1_3-1.3.pdf
241774 PerformanceSite_2_0-2.0.pdf
Optional forms
241774 RR_SubawardBudget30_1_3-1.3.pdf
241774 PlannedReport-1.0.pdf
241774 PHS398_CumulativeInclusionReport-1.0.pdf
241774 PHS398_ModularBudget_1_2-1.2.pdf
241774 RR_Budget_1_3-1.3.pdf
Package 2
Mandatory forms
241774 RR_SF424_2_0-2.0.pdf
241774 PHS398_CoverPageSupplement_3_0-3.0.pdf
241774 RR_OtherProjectInfo_1_3-1.3.pdf
241774 PerformanceSite_2_0-2.0.pdf
241774 RR_KeyPersonExpanded_2_0-2.0.pdf
241774 PHS398_ResearchPlan_3_0-3.0.pdf
Optional forms
241774 RR_Budget_1_3-1.3.pdf
241774 RR_SubawardBudget30_1_3-1.3.pdf
241774 PHS398_ModularBudget_1_2-1.2.pdf
241774 PHS_Inclusion_Enrollment_Report-1.0.pdf
241774 PHS_AssignmentRequestForm-1.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
